Jean-Marc Sabate1,2, Muriel Coupaye3, Séverine Ledoux3,4, Benjamin Castel5, Simon Msika5,4, Benoit Coffin6,4, Pauline Jouet6. 1. Service de Gastroentérologie, AP-HP, Hôpital Louis Mourier, HUPNVS, 178 rue des Renouillers, Colombes, France. jean-marc.sabate@aphp.fr. 2. Faculté de médecine, Denis Diderot Paris 7, 75010, Paris, France. jean-marc.sabate@aphp.fr. 3. Service d'Explorations Fonctionnelles, Centre Intégré Nord Francilien de prise en charge de l'Obésité (CINFO), AP-HP, Hôpital Louis Mourier, HUPNVS, Colombes, France. 4. Faculté de médecine, Denis Diderot Paris 7, 75010, Paris, France. 5. Service de Chirurgie digestive, Centre Intégré Nord Francilien de prise en charge de l'Obésité (CINFO), AP-HP, Hôpital Louis Mourier, HUPNVS, Colombes, France. 6. Service de Gastroentérologie, AP-HP, Hôpital Louis Mourier, HUPNVS, 178 rue des Renouillers, Colombes, France.
Abstract
BACKGROUND AND AIMS: Small intestinal bacterial overgrowth (SIBO) has been described in obese patients. The aim of this study was to prospectively evaluate the prevalence and consequences of SIBO in obese patients before and after bariatric surgery. PATIENTS AND METHODS: From October 2001 to July 2009, in obese patients referred for bariatric surgery (BMI >40 kg/m2 or >35 in association with comorbidities), a glucose hydrogen (H2) breath test (BT) was performed before and/or after either Roux-en-Y gastric bypass (RYGBP) or adjustable gastric banding (AGB) to assess the presence of SIBO. Weight loss and serum vitamin concentrations were measured after bariatric surgery while a multivitamin supplement was systematically given. RESULTS: Three hundred seventy-eight (mean ± SD) patients who performed a BT before and/or after surgery were included: before surgery, BT was positive in 15.4 % (55/357). After surgery, BT was positive in 10 % (2/20) of AGB and 40 % (26/65) of RYGBP (p < 0.001 compared to preoperative situation). After RYGBP, patients with positive BT had similar vitamin levels, a lower caloric intake (983 ± 337 vs. 1271 ± 404 kcal/day, p = 0.014) but a significant lower weight loss (29.7 ± 5.6 vs. 37.7 ± 12.9 kg, p = 0.002) and lower percent of total weight loss (25.6 ± 6.0 vs. 29.2 ± 6.9 %, p = 0.044). CONCLUSION: In this study, SIBO is present in 15 % of obese patients before bariatric surgery. This prevalence does not increase after AGB while it rises up to 40 % of patients after RYGBP and it is associated with lower weight loss.
BACKGROUND AND AIMS: Small intestinal bacterial overgrowth (SIBO) has been described in obesepatients. The aim of this study was to prospectively evaluate the prevalence and consequences of SIBO in obesepatients before and after bariatric surgery. PATIENTS AND METHODS: From October 2001 to July 2009, in obesepatients referred for bariatric surgery (BMI >40 kg/m2 or >35 in association with comorbidities), a glucosehydrogen (H2) breath test (BT) was performed before and/or after either Roux-en-Y gastric bypass (RYGBP) or adjustable gastric banding (AGB) to assess the presence of SIBO. Weight loss and serum vitamin concentrations were measured after bariatric surgery while a multivitamin supplement was systematically given. RESULTS: Three hundred seventy-eight (mean ± SD) patients who performed a BT before and/or after surgery were included: before surgery, BT was positive in 15.4 % (55/357). After surgery, BT was positive in 10 % (2/20) of AGB and 40 % (26/65) of RYGBP (p < 0.001 compared to preoperative situation). After RYGBP, patients with positive BT had similar vitamin levels, a lower caloric intake (983 ± 337 vs. 1271 ± 404 kcal/day, p = 0.014) but a significant lower weight loss (29.7 ± 5.6 vs. 37.7 ± 12.9 kg, p = 0.002) and lower percent of total weight loss (25.6 ± 6.0 vs. 29.2 ± 6.9 %, p = 0.044). CONCLUSION: In this study, SIBO is present in 15 % of obesepatients before bariatric surgery. This prevalence does not increase after AGB while it rises up to 40 % of patients after RYGBP and it is associated with lower weight loss.
Entities:
Keywords:
Microbiota; Roux-en-Y gastric bypass; Small intestinal bacterial overgrowth; Vitamins; Weight loss
Authors: C Poitou Bernert; C Ciangura; M Coupaye; S Czernichow; J L Bouillot; A Basdevant Journal: Diabetes Metab Date: 2007-01-26 Impact factor: 6.041
Authors: Gavitt A Woodard; Betsy Encarnacion; John R Downey; Joseph Peraza; Karen Chong; Tina Hernandez-Boussard; John M Morton Journal: J Gastrointest Surg Date: 2009-04-18 Impact factor: 3.452
Authors: Pichamol Jirapinyo; Tracy T Makuvire; William Y Dong; Walter W Chan; Christopher C Thompson Journal: Obes Surg Date: 2019-03 Impact factor: 4.129
Authors: Russell D Dolan; Jason Baker; Kimberly Harer; Allen Lee; William Hasler; Richard Saad; Allison R Schulman Journal: Obes Surg Date: 2020-10-12 Impact factor: 4.129
Authors: Aleksander Eiken; Stefan Fuglsang; Markus Eiken; Maria S Svane; Rune E Kuhre; Nicolai J Wewer Albrechtsen; Svend H Hansen; Samuel A J Trammell; Jens S Svenningsen; Jens F Rehfeld; Kirstine N Bojsen-Møller; Nils B Jørgensen; Jens J Holst; Sten Madsbad; Jan L Madsen; Carsten Dirksen Journal: Int J Obes (Lond) Date: 2020-04-21 Impact factor: 5.095
Authors: Matthew Bohm; Andrea Shin; Sean Teagarden; Huiping Xu; Anita Gupta; Robert Siwiec; David Nelson; John M Wo Journal: J Clin Gastroenterol Date: 2020-02 Impact factor: 3.174
Authors: Yves M Borbély; Alice Osterwalder; Dino Kröll; Philipp C Nett; Roman A Inglin Journal: World J Gastroenterol Date: 2017-07-14 Impact factor: 5.742